glp-1 safety concerns Do The Benefits of Drugs OutWeigh the Negatives? The promise and peril of

The medication is administered through a small injection, typically once per week, in the comfort of the clinic or at home

Unmet Needs and Scope The four pressing unmet needs in the management of T2DM, within the scope of this paper, include: 1

The initial muscle loss seen with GLP-1 RA treatment as well as the ongoing replacement of muscle with fat with treatment cycles involving treatment interruptions can result in unfavorable changes in body composition in patients with obesity that can have profoundly negative repercussions, and can exacerbate obesity-related metabolic and health concerns 14,15,16

Knowing what to say when requesting GLP-1 options from healthcare providers can help navigate these conversations more effectively

Dermawan D, Purbayanto MAK, An overview of advancements in closed-loop artificial pancreas system